Input Stories

Johnson & Johnson recently announced a $2 billion investment, which will expand its operations in North Carolina with a 160,000+ square foot manufacturing facility at FUJIFILM’s new biopharmaceutical manufacturing site in Holly Springs.

• The investment will bring about 120 new jobs to the area.

Thanks to tax reform: In its announcement, the company explicitly attributed this investment to the recent passage of legislation that secured pro-growth, pro-manufacturing tax provisions—a victory for the NAM and all manufacturers in the U.S.

• “Johnson & Johnson has more manufacturing facilities in the U.S. than in any other country, and we continue to strengthen our presence here,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “With the recent signing of the One Big Beautiful Bill Act, we continue to expand our investment in the U.S. to lead the next era of healthcare innovation.”

Previous investment: Johnson & Johnson announced in March that it would invest more than $55 billion in its U.S. operations over the next four years.

NAM and J&J: The new investment was also celebrated by Johnson & Johnson Executive Vice President, Chief Technical Operations & Risk Officer and NAM Board Chair Kathy Wengel.

• “Today marks an exciting milestone for [Johnson & Johnson] and for the future of healthcare innovation in the United States. We’re proud to be building capabilities and partnerships that enable faster, flexible expansion of our manufacturing to meet the needs of patients who rely on us every day, and create high-paying jobs here in the U.S.,” she said.

The last word: “Johnson & Johnson continues to expand manufacturing in America, creating new jobs and increasing investments. As NAM Board Chair, Kathy worked tirelessly to ensure Congress and the administration delivered the pro-growth tax policies our industry needs to grow, compete and win,” said NAM President and CEO Jay Timmons.